
Orbis Medicinesrevenue
Frederiksberg, DenmarkFounded 2021CEO Maureen Brinkman
Orbis Medicines is a biotechnology company focused on pioneering a new era for oral macrocycle drug discovery.
Orbis Medicines revenue
Orbis Medicines has not published its revenue. Growjo puts it at about $7.6M a year (September 2025).
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $7.6MEST | Growjo estimate |
Orbis Medicines CEO & employees
Maureen Brinkman is CEO of Orbis Medicines. Orbis Medicines has 43 employees (September 2025, LinkedIn).
Orbis Medicines FAQ
What is Orbis Medicines' revenue?
Growjo estimates Orbis Medicines' revenue at about $7.6M a year (September 2025). The company hasn't published its own figure.
How many employees does Orbis Medicines have?
Orbis Medicines has 43 employees as of September 2025, according to LinkedIn.
Who is the CEO of Orbis Medicines?
Maureen Brinkman is the CEO of Orbis Medicines.
Categories
Companies in
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Orbis Medicines? Join the podcast